While in vitro investigations examining the direct application of TTFields to T cells have demonstrated some level of proliferation inhibition of CD8+ and CD4+ cells without affecting any of their other anti-tumoral functions [38], in the current in vivo study, TTFields did not seem to impede tumor T cell levels. The gene discussed is CD8A; the disease is neoplasm.